Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 1:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1417–1440 of 13,937 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: PTSD, Alcohol Abuse, Alcoholism
Interventions: Topiramate, Placebo administration; Drug · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Prostate Cancer
Interventions: Exercise and Diet; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older · Male only
Enrollment: 204 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Adolescent Behavior, Emergency Department, Abuse Physical, Abuse Mental, Abuse Verbal, Abuse Domestic, HEART, Intimate Partner Violence
Interventions: ED-HEART; Behavioral
Lead sponsor: Children's Mercy Hospital Kansas City; Other
Eligibility: 14 Years to 19 Years
Enrollment: 175 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Subjective Cognitive Decline
Interventions: Internet-based Mindfulness-Based Stress Reduction (iMBSR), Internet-based Lifestyle Education (iLifeEd); Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 50 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Nephrolithiasis
Interventions: Fexofenadine Hcl 180Mg Tab, Placebo; Drug
Lead sponsor: Columbia University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: ADHD, Anxiety, Generalized Anxiety, Social Anxiety Disorder
Interventions: Centanafadine, Placebo; Drug · Other
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 315 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 46
States / cities: Dothan, Alabama • Little Rock, Arkansas • Rogers, Arkansas + 41 more

Conditions: Epigenetic Aging, Immunosenescence
Interventions: TRIIM Treatment, Active Control; Combination Product
Lead sponsor: Intervene Immune, Inc.; Industry
Eligibility: 40 Years to 80 Years
Enrollment: 85 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2025
U.S. locations: 1
States / cities: Torrance, California

Conditions: Skin Ulcers, Sickle Cell Anemia
Interventions: Arginine Butyrate, Standard local care dressing; Drug · Other
Lead sponsor: Susan P. Perrine; Other
Eligibility: 16 Years to 60 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2005
U.S. locations: 4
States / cities: Chicago, Illinois • Boston, Massachusetts • New York, New York + 1 more

Conditions: Advanced Solid Tumor, Pain
Interventions: Meaning-Centered Pain Coping Skills Training; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 211 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Diabetes Mellitus, Type 2
Interventions: CBT/CMT, Control group traditional primary care; Behavioral · Other
Lead sponsor: Community Wellness Center, West Linn, OR; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: West Linn, Oregon

Conditions: Contrast Medium-induced Nephropathy
Interventions: LVEDP -Based hydration strategy, Standard hydration; Other
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years and older
Enrollment: 396 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Anemia
Interventions: Epoetin Alfa; Drug
Lead sponsor: Mehrotra, Anita, M.D.; Individual
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Overactive Bladder (OAB)
Interventions: NT 201 200U and Vibe System, NT 201 300U and Vibe System, Placebo and sham; Combination Product
Lead sponsor: Vensica Therapeutics Ltd.; Industry
Eligibility: 18 Years to 80 Years · Female only
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 3
States / cities: Margate, Florida • Pompano Beach, Florida • Reno, Nevada

Conditions: Smoking Cessation
Interventions: Quitxt text messaging or Chat, Usual care; Behavioral · Other
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years to 29 Years
Enrollment: 1,200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Motivation, Stress Disorder, Post Traumatic Stress Disorder, Depression, Depressive Disorder
Interventions: Financial Incentive; Behavioral
Lead sponsor: Christopher Cronin; Other
Eligibility: 18 Years and older
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 3
States / cities: Dallas, Texas • Denton, Texas • Fort Worth, Texas

Conditions: Orthopedic Devices Associated With Misadventures
Interventions: Tenex Procedure, Open Debridement Surgical Intervention Treatment Plan; Procedure
Lead sponsor: Sean Mc Millan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 10
States / cities: Burlington, New Jersey • Cherry Hill, New Jersey • Moorestown, New Jersey + 4 more

Conditions: Brain Injuries
Interventions: Problem-solving, education based telephone counseling, No Intervention; Behavioral · Other
Lead sponsor: University of Washington; Other
Eligibility: 16 Years and older
Enrollment: 153 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Burnout, Professional
Interventions: Coaching, Wellness resources; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Female only
Enrollment: 237 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Melanoma (Skin Cancer), Melanoma Stage IIIB-IV, Cutaneous Melanoma, Unresectable Melanoma
Interventions: LNS8801, Pembrolizumab, Chemotherapy (dacarbazine or temozolomide), Immunotherapy (Pembrolizumab), Immunotherapy (nivolumab and relatlimab), Immunotherapy (ipilimumab and nivolumab); Biological · Drug
Lead sponsor: Linnaeus Therapeutics, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 135 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 9
States / cities: Newport Beach, California • San Francisco, California • Stanford, California + 6 more

Conditions: Pain, Postoperative
Interventions: Ibuprofen 600 mg, Local anesthetic Group 1, Placebo oral capsule, Local anesthetic Control; Drug
Lead sponsor: Satheesh Elangovan; Other
Eligibility: 18 Years to 64 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Obesity and Overweight
Interventions: Commercial weight management program; Behavioral
Lead sponsor: WW International Inc; Industry
Eligibility: 18 Years and older
Enrollment: 459 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Recurrent Urinary Tract Infection
Interventions: Estradiol vaginal cream, Estradiol Vaginal Tablet; Drug
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 20 Years to 80 Years · Female only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Tobacco-Related Carcinoma
Interventions: Health Education, Interview, Smoking Cessation Intervention, Survey Administration, Text Message-Based Navigation Intervention; Behavioral · Other
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years to 35 Years
Enrollment: 292 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Internal Carotid Artery Stenosis, Cognitive Impairment
Interventions: Revascularization, Intensive Medical Management (IMM) alone; Procedure · Other
Lead sponsor: Columbia University; Other
Eligibility: 35 Years to 86 Years
Enrollment: 392 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2025
U.S. locations: 56
States / cities: Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 45 more

Search by objective public record fields.

Topiramate Treatment of Alcohol Use Disorders in Veterans With Post Traumatic Stress Disorder (PTSD): A Pilot Controlled Trial of Augmentation Therapy

Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)

Emergency Department Healthcare Education Assessment and Response for Teen Relationships: A Pilot Feasibility Study

Internet-based Mind-Body Training for Brain Health

Effect of Antihistamines on Ureteral Stent-Related Symptoms

P3b Short-term Study of CTN in Patients With ADHD and Comorbid Anxiety

Thymus Regeneration, Immunorestoration, and Insulin Mitigation Extension Trial

Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell Ulcers

Meaning-Centered Pain Coping Skills Training for Cancer Pain

Effect of Manual Medicine or Cognitive Behavioral Therapy With Chronic Uncontrolled Diabetes

Prevention of Contrast Renal Injury With Different Hydration Strategies

Study of Epoetin Alfa to Treat Anemia After Kidney Transplantation

RELIEVE Study: NT 201 Intravesical Administration Using Vibe System (ViXe Combination Product) for the Treatment of Idiopathic Overactive Bladder

Quitxt Mobile Text Messaging Cessation Research Study

Financial Incentives for Veteran Therapy Completion

Randomized Controlled Trial (RCT) of Open Debridement Versus Tenex

Telephone Intervention for Caregivers of Persons With Traumatic Brain Injury

Investigating the Impact of Professional Development Coaching Programs in Residents & Fellows

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Pre-Emptive Analgesia in Dental Implant Surgery

A Randomized Controlled Trial Comparing the Efficacy of Commercial Weight Management Programs

Preference of Women With Recurrent Urinary Tract Infection for Vaginal Estradiol Tablet vs Cream

Nicotine and Tobacco Message Framing to Change Smoking Behavior in Diverse Groups of Young Adult Smokers

Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial - Hemodynamics (CREST-H)